siegel is "outnumbered," as we say come in the center box. good to see if ready today. see to mike doc, will come to first. let's talk about the second wave that will be coming, and what cdc director redfield is saying, and others. what is your take on it? >> dr. siegel: actually, harris, a spoke to dr. redfield about this last week. the exact thing. i have a different take. here's what i think -- i think he expects, and he told me this, do have extensive testing in place by the fall. i'm talking about rapid testing and antibody testing. he thinks that will help us to control it by then. we'll have the exact science we need. secondly, the good side of this is he feels -- and dr. fauci has told me the same thing -- they feel this virus is starting to look seasonal. that would mean that dr. redfield expects it to flatten out by the summer, by june, by the end of may, june. that's also good news. then i said to him, "what about australia, what about the southern hemisphere? if you think this is seasonal, doesn't what's happening in australia now predict what might happen here i in the fal

doc siegel, thank you very much indeed on a friday morning. thank you, sir. all right. >>> i've got news on amazon. there's always news on amazon. the stock is up 18 bucks. what have you got today, susan? susan: an investigative report by the "wall street journal" saying that amazon is abusing its position as a marketplace but also taking that data from independent sellers and then making its own products and probably making it better and pricing it better as well. it looks like the "wall street journal" interviewed around 20 past employees and they say we were able to access this data, this is an open policy that a lot of people actually participated in. now, one example they gave, i don't know if we have that picture, but it is the trunk organizer that amazon basically copied off a third party seller. now, amazon first told us in a statement, saying that actually we don't allow this to happen as a company, if we can bring up also the statement as well, that we will look into this in an internal investigation. amazon says there are restrictions in terms of w

so they walked it back and doc siegel told me just moments ago that the remdesivir, the gilead sciences drug is best used in the early stages of the disease. so ever so slightly lower after a drop yesterday. >> sandra: the confusion was whether or not that highly promising treatment failed, which was originally reported and set markets on a wild ride or whether it was ultimately determined inconclusive because it had to end early. meanwhile, we have another round of stimulus. what's that doing for markets and optimism about the economy when we put this all behind us? >> i think it helps the markets. we got another what $310 plus being pumped out there relatively quickly, it is the rescue. it's not a stimulus package, it's a rescue of the economy which is in the depths of despair right now. so the market likes that idea of rescuing the economy. however they are looking also at another round of big spending. i don't know how much it's going to be but they are looking at another stimulus or rescue package and that will be number five. there's a lot of bulking at that now. a lot of people a

stuart: doc siegel, thanks for jumping on so quickly. this news broke literally 25, 30 minutes ago. thank you very much. >>> let's get back to the economy. it's shrinking at an annual rate of 4.8% in the first quarter of this year. john lonski, economist at moody's, is with us. it's bad in the first quarter, probably getting worse in the second quarter, april, may and june. does this change your outlook for the recovery on the other side? >> i still think we will look at a fairly vigorous recovery. we should have double digit percentage growth in the third quarter, maybe slowing down a bit in the fourth quarter. but what's important to remember is that the equity market has been moving higher. my goodness, it's up by more than 25% from its low of march 23rd so the equity market believes that economic growth will be sufficient so that profits growth can become a recurring phenomenon and if that's the case, a lot of these jobs that have been lost are going to be returning. stuart: okay. john, real fast, positive results from the remdesivir trial, a treatment for the virus, looks promi